Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer

Urology

Volumn 60, Issue 5, 2002, Pages 841-845

  Taylor III, John A ^a   Gancarczyk, Kevin J ^a   Fant, Gregory V ^a   Mcleod, David G ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DATA BASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; STATISTICAL SIGNIFICANCE; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0036844761     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01878-2     Document Type: Article

References (12)

1. American Cancer Society: Cancer Facts and Figures, 2002.
2. Epstein J.I., Walsh P.C., Brendler C.B. Radical prostatectomy for impalpable prostate cancer The Johns Hopkins experience with tumors found on transurethral resection (stages T1a and T1b) and on needle biopsy (stage T1c) . J Urol. 152:1994;1721-1729.
3. Dugan J.A., Bostwick D.G., Myers R.P., et al. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA. 275:1996;288-294.
4. Teneja S.S., Penson D.F., Epelbaum A., et al. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen. J Urol. 162:1999;1352-1357.
5. Epstein J.I., Lecksell K., Carter H.B. Prostate cancer sampled on sextant needle biopsy significance of cancer on multiple cores from different areas of the prostate . Urology. 54:1999;291-294.
6. Chang J.J., Shinohara K., Bhargava V., et al. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol. 160:1998;2111-2114.
7. Terris M.K., Wallen E.M., Stamey T.A. Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int. 59:1997;239-242.
8. Naughton C.K., Smith D.S., Humphrey P.A., et al. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores a retrospective study . Urology. 52:1998;808-813.
9. Bauer J.J., Zeng J., Weir J., et al. Three-dimensional computer-simulated prostate models lateral prostate biopsies increase the detection rate of prostate cancer . Urology. 53:1999;961-967.
10. Babian R.J., Toi A., Kamoi K., et al. A comparative analysis of sextant and an 11-core multisite directed biopsy strategy. J Urol. 163:2000;152-157.
11. Epstein J.I., Walsh P.C., Carter H.B. Importance of posterolateral needle biopsies in the detection of prostate cancer. Urology. 57:2001;1112-1116.
12. Hodge K.K., McNeal S.E., Terris M.K., et al. Random systematic versus directed ultrasound-guided transrectal core biopsies of the prostate. J Urol. 142:1989;71-74.